Literature DB >> 19205950

Concurrent validity of the tower tasks as measures of executive function in adults: a meta-analysis.

Jeremy R Sullivan1, Cynthia A Riccio, Christine L Castillo.   

Abstract

Executive function refers to a variety of behaviors and abilities related to planning and strategy use, as well as to the maintenance of attention and behavior in the pursuit of some goal. Many instruments have been designed for the purpose of assessing executive function, and the tower tasks represent a specific group of measures commonly used in the assessment of this construct. This review and meta-analysis examines the theoretical and psychometric basis for the use of the various tower tasks in neuropsychological assessment of adults. Neuroimaging and electrophysiological evidence are consistent with theoretical hypotheses of frontal involvement (e.g., planning and strategy use) in tower task performance. Further, adults with various disorders of presumed neurological basis demonstrate impaired performance on tower tasks. Implications for the use of tower tasks in practice and research are discussed.

Mesh:

Year:  2009        PMID: 19205950     DOI: 10.1080/09084280802644243

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  23 in total

1.  Differential impact of continuous theta-burst stimulation over left and right DLPFC on planning.

Authors:  Christoph P Kaller; Katharina Heinze; Annekathrein Frenkel; Claus H Läppchen; Josef M Unterrainer; Cornelius Weiller; Rüdiger Lange; Benjamin Rahm
Journal:  Hum Brain Mapp       Date:  2011-10-14       Impact factor: 5.038

2.  Set-shifting as a component process of goal-directed problem-solving.

Authors:  Richard P Cooper; Verity Marsh
Journal:  Psychol Res       Date:  2015-02-17

3.  Therapeutic Opportunities for Self-Control Repair in Addiction and Related Disorders: Change and the Limits of Change in Trans-Disease Processes.

Authors:  Warren K Bickel; Amanda J Quisenberry; Lara Moody; A George Wilson
Journal:  Clin Psychol Sci       Date:  2015-01-01

4.  The Tower of London (ToL) in Italy: standardization of the ToL test in an Italian population.

Authors:  Maddalena Boccia; Dario Marin; Giovanni D'Antuono; Paola Ciurli; Chiara Incoccia; Gabriella Antonucci; Cecilia Guariglia; Laura Piccardi
Journal:  Neurol Sci       Date:  2017-04-21       Impact factor: 3.307

5.  Age and IQ Explained Working Memory Performance in a RCT with Fatty Fish in a Group of Forensic Inpatients.

Authors:  A L Hansen; G Ambroziak; D Thornton; L Dahl; B Grung
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

6.  Associations of Anger and Fear to Later Self-Regulation and Problem Behavior Symptoms.

Authors:  Sara S Nozadi; Tracy L Spinrad; Nancy Eisenberg; Natalie D Eggum-Wilkens
Journal:  J Appl Dev Psychol       Date:  2015 May-Jun

7.  Evaluation of specific executive functioning skills and the processes underlying executive control in schizophrenia.

Authors:  Gauri N Savla; Elizabeth W Twamley; Wesley K Thompson; Dean C Delis; Dilip V Jeste; Barton W Palmer
Journal:  J Int Neuropsychol Soc       Date:  2010-11-10       Impact factor: 2.892

8.  Problem-solving deficits in methcathinone use disorder.

Authors:  Hang-Bin Zhang; Di Zhao; Yu-Ping Liu; Li-Xun Wang; Bo Yang; Ti-Fei Yuan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

9.  A Meta-analysis on the neural basis of planning: Activation likelihood estimation of functional brain imaging results in the Tower of London task.

Authors:  Kai Nitschke; Lena Köstering; Lisa Finkel; Cornelius Weiller; Christoph P Kaller
Journal:  Hum Brain Mapp       Date:  2016-09-15       Impact factor: 5.038

10.  Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease.

Authors:  Kathryn V Papp; Peter J Snyder; James A Mills; Kevin Duff; Holly J Westervelt; Jeffrey D Long; Spencer Lourens; Jane S Paulsen
Journal:  Arch Clin Neuropsychol       Date:  2012-12-16       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.